310 related articles for article (PubMed ID: 19144367)
1. An examination of the activity of expired and mistreated commercial Australian antivenoms.
O'Leary MA; Kornhauser RS; Hodgson WC; Isbister GK
Trans R Soc Trop Med Hyg; 2009 Sep; 103(9):937-42. PubMed ID: 19144367
[TBL] [Abstract][Full Text] [Related]
2. Antivenom efficacy or effectiveness: the Australian experience.
Isbister GK
Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
[TBL] [Abstract][Full Text] [Related]
3. Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms.
Silva A; Hodgson WC; Isbister GK
Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27763543
[TBL] [Abstract][Full Text] [Related]
4. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms.
Chetty N; Du A; Hodgson WC; Winkel K; Fry BG
Toxicon; 2004 Aug; 44(2):193-200. PubMed ID: 15246769
[TBL] [Abstract][Full Text] [Related]
5. Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?
O'Leary MA; Schneider JJ; Krishnan BP; Lavis C; McKendry A; Ong LK; Isbister GK
Toxicon; 2007 Aug; 50(2):206-13. PubMed ID: 17467763
[TBL] [Abstract][Full Text] [Related]
6. Cross-neutralisation of Australian brown snake, taipan and death adder venoms by monovalent antibodies.
Isbister GK; O'Leary MA; Hagan J; Nichols K; Jacoby T; Davern K; Hodgson WC; Schneider JJ
Vaccine; 2010 Jan; 28(3):798-802. PubMed ID: 19879227
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxic effects of venoms from seven species of Australasian black snakes (Pseudechis): efficacy of black and tiger snake antivenoms.
Ramasamy S; Fry BG; Hodgson WC
Clin Exp Pharmacol Physiol; 2005; 32(1-2):7-12. PubMed ID: 15730427
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
Ramasamy S; Isbister GK; Hodgson WC
Toxicon; 2004 Dec; 44(8):837-45. PubMed ID: 15530965
[TBL] [Abstract][Full Text] [Related]
10. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Australian and Asian Commercial Antivenoms in Reversing the Post-Synaptic Neurotoxicity of
Huynh TM; Hodgson WC; Isbister GK; Silva A
Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448886
[TBL] [Abstract][Full Text] [Related]
12. The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro.
Barfaraz A; Harvey AL
Toxicon; 1994 Mar; 32(3):267-72. PubMed ID: 8016849
[TBL] [Abstract][Full Text] [Related]
13. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the neurotoxic and myotoxic effects of Brazilian Bothrops venoms and their neutralization by commercial antivenom.
Zamunér SR; da Cruz-Höfling MA; Corrado AP; Hyslop S; Rodrigues-Simioni L
Toxicon; 2004 Sep; 44(3):259-71. PubMed ID: 15302532
[TBL] [Abstract][Full Text] [Related]
15. Development of a sensitive enzyme immunoassay for measuring taipan venom in serum.
Kulawickrama S; O'Leary MA; Hodgson WC; Brown SG; Jacoby T; Davern K; Isbister GK
Toxicon; 2010 Jul; 55(8):1510-8. PubMed ID: 20223258
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of the neuromuscular inhibition of venom and taipoxin from the taipan (Oxyuranus scutellatus) by F(ab')2 and whole IgG antivenoms.
Herrera M; de Cássia de O Collaço R; Villalta M; Segura Á; Vargas M; Wright CE; Paiva OK; Matainaho T; Jensen SD; León G; Williams DJ; Rodrigues-Simioni L; Gutiérrez JM
Toxicol Lett; 2016 Jan; 241():175-83. PubMed ID: 26621539
[TBL] [Abstract][Full Text] [Related]
17. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
O'Leary MA; Isbister GK
Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Neurotoxicity of Chinese Krait (
Liang Q; Huynh TM; Ng YZ; Isbister GK; Hodgson WC
Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33440641
[No Abstract] [Full Text] [Related]
19. In-Vitro Neutralization of the Neurotoxicity of Coastal Taipan Venom by Australian Polyvalent Antivenom: The Window of Opportunity.
Madhushani U; Isbister GK; Tasoulis T; Hodgson WC; Silva A
Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142783
[TBL] [Abstract][Full Text] [Related]
20. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25).
Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK
Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
